Screener
Astrana Health ASTH Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$972.5MMiss by $9.7M
EPS$0.40Beat by $0.06
Revenue estimate$982.2M
EPS estimate$0.34
“Our second quarter results reflect the strength of Astrana's physician-centric, AI-native healthcare operating system and the disciplined execution of our team. We continue to see accelerating demand from both providers and payers for our platform, driving strong growth, record-high adjusted diluted EPS, and robust free cash flow generation. Our performance gives us the confidence to raise our adjusted EBITDA guidance for 2026 even as we reinvest a substantial portion of our first-half outperformance into attractive growth opportunities that we believe will further strengthen our earnings power over time.”
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$1.0B
EPS estimate$0.42
Valuation & ratios
Valuation
as of 09/16/26Versus estimates
Revenue
Diluted EPS
FAQ
- When did Astrana Health report Q2 2026 earnings?
- Astrana Health (ASTH) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Astrana Health's Q2 2026 revenue and EPS?
- Astrana Health reported revenue of $972.5M and eps of $0.40 for Q2 2026.
- Did Astrana Health beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $982.2M by $9.7M. EPS beat the consensus estimate of $0.34 by $0.06.
- How did Astrana Health's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 48.5% from $654.8M a year earlier and eps grew 110.5% from $0.19.
- Where can I find Astrana Health's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-092003) and the 10-Q periodic report (0001193125-26-342631) directly on SEC EDGAR. The filing index links above go to sec.gov.
